Switzerland
Viselio AG, established in 2016, is strategically positioned within the Travel and Tourism sector. The company's mission has been compellingly adapted to the current global health climate, providing COVID-19 Test Centers in Switzerland renowned for their high medical standards. Key locations include Bern Main Station and Zurich Airport, underscoring their commitment to accessibility and convenience.
Headquartered in Switzerland, Viselio AG distinguishes itself by integrating medical excellence with the country's strong reputation for healthcare standards. The company's last major financial milestone was a Fr.3.00M Series A investment on 28 February 2020, led by notable investors including Howzat Partners, EquityPitcher Ventures, Innuvik Ventures, and the Kuoni Group. This investment reflects significant confidence in Viselio AG's ability to meet evolving travel needs amidst public health concerns, positioning it as a robust potential prospect for future investment.
